Drug Shortage Report for SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES

Last updated on 2024-12-11 History
Report ID 213804
Drug Identification Number 02513803
Brand name SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES
Common or Proper name DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) DIMETHYL FUMARATE
Strength(s) 240MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL
Packaging size 56GRC
ATC code L04AX
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-12-19
Estimated end date
Actual end date 2024-12-10
Shortage status Resolved
Updated date 2024-12-11
Company comments Discontinued
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2024-12-11 English Compare
v7 2024-12-10 French Compare
v6 2024-12-10 English Compare
v5 2024-02-05 French Compare
v4 2024-02-05 English Compare
v3 2023-12-20 English Compare
v2 2023-12-19 French Compare
v1 2023-12-19 English Compare

Showing 1 to 8 of 8